CHEMICAL OR BIOLOGICAL AGENTS WHICH

Brand Owner (click to sort) Address Description
ADIPOGEN OSIRIS THERAPEUTICS, INC. 7015 Albert Einstein Drive Columbia MD 21046 chemical or biological agents which cause progenitor cells to be differentiated into fat tissue lineage cells for medical use;
ADIPONEXIN OSIRIS THERAPEUTICS, INC. 7015 Albert Einstein Drive Columbia MD 21046 chemical or biological agents which cause tissue-forming progenitor cells to commit into or produce differentiated adipose tissue in vitro or in vivo for medical use;
CHONDROGEN OSIRIS THERAPEUTICS, INC. 7015 Albert Einstein Drive Columbia MD 21046 chemical or biological agents which cause progenitor cells to differentiate into cartilage tissue lineage cells;
CHONDROGEN OSIRIS THERAPEUTICS, INC. 7015 Albert Einstein Drive Columbia MD 21046 Chemical or biological agents which cause progenitor cells to differentiate into cartilage tissue lineage cells;
CHONDROGEN OSIRIS THERAPEUTICS, INC. 7015 Albert Einstein Drive Columbia MD 21046 CHEMICAL OR BIOLOGICAL AGENTS WHICH CAUSE PROGENITOR CELLS TO DIFFERENTIATE INTO CARTILAGE TISSUE LINEAGE CELLS;
CHONDROPOIETIN OSIRIS THERAPEUTICS, INC. 7015 Albert Einstein Drive Columbia MD 21046 chemical or biological agents which cause progenitor cells to differentiate into cartilage tissue lineage;
CHONDROPOIETIN OSIRIS THERAPEUTICS, INC. 7015 Albert Einstein Drive Columbia MD 21046 Chemical or biological agents which cause progenitor cells to differentiate into cartilage tissue lineage;
DERMAPOIETIN OSIRIS THERAPEUTICS, INC. 7015 Albert Einstein Drive Columbia MD 21046 chemical or biological agents which cause progenitor cells to differentiate into dermis tissue lineage;
DERMAPOIETIN OSIRIS THERAPEUIICS, INC. 2001 Aliceanna Street Baltimore MD 212312001 Chemical or biological agents which cause progenitor cells to differentiate into dermis tissue lineage;
MYOGEN OSIRIS THERAPEUTICS, INC. 7015 Albert Einstein Drive Columbia MD 21046 chemical or biological agents which cause progenitor cells to differentiate into muscle tissue;
MYOPOIETIN OSIRIS THERAPEUTICS, INC. 7015 Albert Einstein Drive Columbia MD 21046 chemical or biological agents which cause progenitor cells to differentiate into muscle tissue lineage;
MYOPOIETIN OSIRIS THERAPEUTICS,INC. 2001 Aliceanna Street Baltimore MD 212312001 Chemical or biological agents which cause progenitor cells to differentiate into muscle tissue lineage;
OSTEOGEN OSIRIS THERAPEUTICS, INC. 7015 Albert Einstein Drive Columbia MD 21046 chemical or biological agents which lead to partial or complete differentiation of mesenchymal progenitor cells or partially differentiated mesenchymal cells into the bone tissue lineage cells;
OSTEOPOIETIN OSIRIS THERAPEUTICS, INC. 7015 Albert Einstein Drive Columbia MD 21046 chemical or biological agents which cause progenitor cells to differentiate into bone tissue lineage;
OSTEOPOIETIN OSIRIS THERAPEUTICS,INC. 2001 Aliceanna Street Baltimore MD 212312001 Chemical or biological agents which cause progenitor cells to differentiate into bone tissue lineage;
PROGENIX OSIRIS THERAPEUTICS, INC. 7015 Albert Einstein Drive Columbia MD 21046 chemical or biological agents which cause tissue-forming progenitor cells to proliferate in vitro or in vivo for medical use;
RIGHT NOW OSIRIS THERAPEUTICS, INC. 7015 Albert Einstein Drive Columbia MD 21046 Chemical or biological agents which cause progenitor cells to differentiate into cartilage tissue lineage cells or which cause progenitor cells to differentiate into bone marrow stroma tissue lineage cells; pharmaceutical compositions, namely, mesenchymal stem cell (MSC) compositions for the regeneration of cardiac tissue and the treatment of heart disease; pharmaceutical compositions containing mesenchymal stem cells and their bone lineage committed descendants which may be combined with a matrix for bone repair and regeneration; cells for medical use for regeneration of human tissue, namely, bone, cartilage, marrow, muscle, adipose, tissue, and tendon composition; pharmaceutical composition containing mesenchymal stem cells which may be administered intravenously for immune response modulation and to affect tissue repair in treating immune and inflammatory disease;
SMART MEDICINE OSIRIS THERAPEUTICS, INC. 7015 Albert Einstein Drive Columbia MD 21046 Chemical or biological agents which cause progenitor cells to differentiate into cartilage tissue lineage cells or which cause progenitor cells to differentiate into bone marrow stroma tissue lineage cells, for medical use; pharmaceutical compositions, namely, mesenchymal stem cell (MSC) compositions for the regeneration of cardiac tissue and the treatment of heart disease; pharmaceutical compositions containing mesenchymal stem cells and their bone lineage committed descendants which may be combined with a matrix for bone repair and regeneration; cells for medical use for regeneration of human tissue, namely, bone, cartilage, marrow, muscle, adipose, tissue, and tendon composition; pharmaceutical composition containing mesenchymal stem cells which may be administered intravenously for immune response modulation and to affect tissue repair in treating immune and inflammatory disease;
STROMAGEN OSIRIS THERAPEUTICS, INC. 7015 Albert Einstein Drive Columbia MD 21046 chemical or biological agents which cause progenitor cells to differentiate cells into bone marrow stroma tissue lineage cells;
STROMAGEN OSIRIS THERAPEUTICS, INC. 7015 Albert Einstein Drive Columbia MD 21046 Chemical or biological agents which cause progenitor cells to differentiate cells into bone marrow stroma tissue lineage cells;
STROMAPOIETIN OSIRIS THERAPEUTICS, INC. 7015 Albert Einstein Drive Columbia MD 21046 chemical or biological agents which cause progenitor cells to differentiate into bone marrow stroma tissue lineage;
STROMAPOIETIN OSIRIS THERAPEUTICS,INC. 2001 Aliceanna Street Baltimore MD 212312001 Chemical or biological agents which cause progenitor cells to differentiate into bone marrow stroma tissue lineage;
TENDOGEN OSIRIS THERAPEUTICS, INC. 7015 Albert Einstein Drive Columbia MD 21046 chemical or biological agents which cause progenitor cells to differentiate into tendon tissue lineage cells;
TENDOGEN OSIRIS THERAPEUTICS,INC. 2001 Aliceanna Street Baltimore MD 212312001 Chemical or biological agents which cause progenitor cells to differentiate into tendon tissue lineage cells;
TENDOPOIETIN OSIRIS THERAPEUTICS, INC. 7015 Albert Einstein Drive Columbia MD 21046 chemical or biological agents which cause progenitor cells to differentiate into tendon tissue lineage;
TENDOPOIETIN OSIRIS THERAPEUTICS,INC. 2001 Aliceanna Street Baltimore MD 212312001 Chemical or biological agents which cause progenitor cells to differentiate into tendon tissue lineage;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. A method and apparatus for neutralizing biological and/or chemical warfare agents using an ozone-containing solution. The ozone-containing solution is produced by combining ozone-containing gas with an ozone vehicle, such as an organic solution. The ozone-vehicle prolongs the shelf life of the ozone to allow for extended periods of storage. A storage container is used to store the ozone-containing solution and facilitate its transportation to an environment contaminated by the biological and/or chemical warfare agents, or near a potential site for biological or chemical attack. The ozone-containing solution is drawn out of the storage container to apply it to a contaminated environment.